DESCRIPTION
Pragmatic trials often aim to take advantage of technology for outreach and implementation, with the goals of broadening outreach and reducing burden on participants. One benefit of such approaches is the reduction in barriers presented by in-person consent processes. Different methods of outreach and consent, however, result in different subpopulations of participants who enroll; both of these features can influence the estimates of treatment effectiveness that may result. We will discuss examples of how these approaches influence outcomes and analytic results, as well as ethical concerns.
LEARNING OBJECTIVES
Participants will gain an understanding of the kinds of electronic platforms available to facilitate pragmatic trials, and will explore the effect of different outreach and consent approaches on participation.
PRESENTER(S)
Andrea Troxel, ScD, is the Director of Biostatistics and Professor of Population Health at New York University. I have extensive experience in the design, implementation, and analysis of clinical trials of all phases, including both pragmatic and adaptive randomized trials. I collaborate with investigators in a wide range of clinical areas, including oncology, cardiology, chronic disease, and behavioral economics. I am also heavily involved in educational activities in biostatistics and clinical trials.
